 SARASOTA, Fla., April 26, 2021 PRNewswire -- INVO Bioscience, Inc. NASDAQ: INVO, a medical device company focused on commercializing the worlds only in vivo Intravaginal Culture System IVC, INVOcell, an effective and affordable treatment for patients diagnosed with infertility, today announced the appointment of Rebecca Messina to the Companys board of directors, effective immediately. 